Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Ir Med J ; 99(5): 148-50, 2006 May.
Article in English | MEDLINE | ID: mdl-16892922

ABSTRACT

Bronchoscopy has evolved well beyond a simple look-see examination, with new interventional techniques becoming more commonly employed. So-called interventional bronchoscopy implies the use of bronchoscopy as a therapeutic, in addition to diagnostic, tool. We present 2 cases to illustrate the utility of one such interventional technique, tumour ablation by endobronchial electrocautery and snaring, in the management of airway obstruction by tumour. This procedure, performed via a flexible bronchoscope under local anaesthesia can spare patients time-consuming, expensive treatments with their attendant morbidity, and in some cases can be life-saving. There is minimal morbidity associated with this technique. It is anticipated that interventional bronchoscopy will continue to revolutionise management of such conditions in the future, and become a necessary facility in all pulmonary medicine units.


Subject(s)
Bronchial Neoplasms/surgery , Bronchoscopy/methods , Electrocoagulation/methods , Aged , Aged, 80 and over , Airway Obstruction/diagnostic imaging , Airway Obstruction/etiology , Bronchial Neoplasms/complications , Bronchial Neoplasms/pathology , Female , Humans , Male , Radiography
2.
Semin Oncol ; 27(3): 335-46, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10864221

ABSTRACT

Significant morbidity and mortality may result from infectious complications in patients with neoplastic disease. Clinical oncologists and infectious disease specialists recognize the emergent nature of these infections in the critically ill patient with cancer. It is essential to have an approach to the understanding of these infections and the circumstances in which they occur. Fever and neutropenia, pneumonia, CNS infections, and gastrointestinal infections are all discussed in this review.


Subject(s)
Fever/etiology , Infections/etiology , Neoplasms/complications , Neutropenia/etiology , Anti-Bacterial Agents/therapeutic use , Critical Illness , Fever/microbiology , Humans , Infections/drug therapy , Neoplasms/microbiology , Neutropenia/microbiology
3.
Int J Infect Dis ; 3(3): 157-60, 1999.
Article in English | MEDLINE | ID: mdl-10460928

ABSTRACT

BACKGROUND: Treatment of invasive aspergillosis is frequently unsuccessful, so innovations in therapy are needed. Clinical studies demonstrate that itraconazole may be an effective alternative to amphotericin B. Itraconazole also has been combined with amphotericin B in animal models of aspergillosis, but this regimen produced antagonistic effects. OBJECTIVES: To determine the role of itraconazole in the adjunctive treatment of invasive aspergillosis. METHODS: A review was conducted of all patients with definite or probable aspergillosis from January 1995 to December 1997 who were treated with conventional amphotericin B alone or in combination with itraconazole. RESULTS: Of 21 patients, 10 received amphotericin B and 11 received the combination. The two groups of patients were comparable clinically at baseline (including similar mean APACHE III scores). Both groups received similar doses and days of amphotericin B treatment. Of the patients who received combination therapy, nine (82%) were cured or improved, and of those who received only amphotericin B, five (50%) were cured or improved. CONCLUSIONS: This study demonstrates that itraconazole and amphotericin B given together are not clinically antagonistic and that the promise of combination therapy for aspergillosis should be evaluated further in a randomized clinical trial.


Subject(s)
Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Aspergillosis/drug therapy , Itraconazole/therapeutic use , APACHE , Adult , Aspergillosis/physiopathology , Drug Therapy, Combination , Female , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome
4.
Riv Inferm ; 15(2): 67-72, 1996.
Article in Italian | MEDLINE | ID: mdl-8868656

ABSTRACT

The incidence of exit-site infections among peritoneal home-dialysis patients was quantified following for 1 year all home dialysis patients of 23 dialysis centres. The exit site conditions were observed and classified according to Twardowsky. When an infection occurred data on its treatment were collected. 393 patients were observed. The infection occurred in 40 patients (10.1%). 82.2% of patients wear a Tenckoff catheter, 3% do not protect the exit site with any kind of dressing. The strategies adopted by different centres vary for the choice of antiseptics, the suggested frequency of changes dressing and the routine use of nasal swabs. Due to the limited number of patients with infection no association was found between tunnel direction or frequency of dressing changes and infections occurrence. Discussion on controversial aspects and the definition of common guidelines for instance for frequency of dressing changes, use of antiseptics is warranted.


Subject(s)
Peritoneal Dialysis/adverse effects , Skin Care , Wound Infection/etiology , Wound Infection/prevention & control , Adult , Aged , Anti-Bacterial Agents/therapeutic use , Bandages , Female , Follow-Up Studies , Home Care Services , Humans , Incidence , Male , Middle Aged , Peritoneal Dialysis/instrumentation , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...